Your browser is no longer supported. Please, upgrade your browser.
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E27.28 EPS (ttm)6.25 Insider Own0.08% Shs Outstand2.63B Perf Week4.73%
Market Cap443.80B Forward P/E18.97 EPS next Y8.99 Insider Trans-4.52% Shs Float2.63B Perf Month12.20%
Income16.69B PEG6.34 EPS next Q1.82 Inst Own69.90% Short Float0.51% Perf Quarter17.38%
Sales80.86B P/S5.49 EPS this Y0.50% Inst Trans-0.03% Short Ratio1.74 Perf Half Y15.83%
Book/sh24.49 P/B6.96 EPS next Y12.36% ROA10.60% Target Price168.18 Perf Year14.61%
Cash/sh11.82 P/C14.42 EPS next 5Y4.30% ROE27.40% 52W Range109.16 - 173.65 Perf YTD8.32%
Dividend4.04 P/FCF55.59 EPS past 5Y-0.20% ROI17.30% 52W High-1.83% Beta0.73
Dividend %2.37% Quick Ratio1.20 Sales past 5Y2.00% Gross Margin65.80% 52W Low56.17% ATR2.93
Employees132200 Current Ratio1.50 Sales Q/Q1.70% Oper. Margin23.60% RSI (14)79.48 Volatility1.80% 1.52%
OptionableYes Debt/Eq0.59 EPS Q/Q102.80% Profit Margin21.00% Rel Volume1.86 Prev Close170.48
ShortableYes LT Debt/Eq0.51 EarningsJan 26 BMO Payout60.80% Avg Volume7.73M Price170.48
Recom1.90 SMA206.58% SMA5010.99% SMA20014.74% Volume0 Change0.00%
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Jan-27-21 07:00AM  
06:30AM  
Jan-26-21 09:10PM  
04:58PM  
04:23PM  
04:22PM  
04:21PM  
04:00PM  
03:01PM  
02:52PM  
02:40PM  
01:42PM  
01:35PM  
01:17PM  
12:59PM  
12:39PM  
12:25PM  
12:23PM  
12:19PM  
11:53AM  
11:30AM  
11:28AM  
11:23AM  
10:55AM  
10:51AM  
10:35AM  
10:27AM  
10:22AM  
10:10AM  
10:01AM  
09:55AM  
08:55AM  
08:39AM  
08:05AM  
07:48AM  
07:31AM  
06:40AM  
06:30AM  
06:20AM  
06:09AM  
Jan-25-21 11:16PM  
05:46PM  
04:38PM  
04:36PM  
04:35PM  
03:17PM  
03:10PM  
01:21PM  
12:37PM  
11:42AM  
11:21AM  
10:03AM  
02:00AM  
Jan-24-21 09:15AM  
07:10AM  
06:35AM  
Jan-23-21 09:38AM  
09:14AM  
06:55AM  
Jan-22-21 04:28PM  
04:08PM  
03:22PM  
09:35AM  
09:26AM  
08:40AM  
08:27AM  
08:00AM  
06:43AM  
06:16AM  
Jan-21-21 05:32PM  
04:53PM  
09:59AM  
04:00AM  
Jan-20-21 05:45PM  
11:11AM  
Jan-19-21 01:08PM  
09:53AM  
Jan-18-21 10:51AM  
03:42AM  
Jan-15-21 03:11PM  
10:11AM  
08:27AM  
04:58AM  
Jan-14-21 05:45PM  
04:55PM  
03:16PM  
01:12PM  
11:44AM  
09:51AM  
08:09AM  
07:58AM  
02:08AM  
Jan-13-21 11:11PM  
09:08PM  
07:42PM  
05:44PM  
05:32PM  
03:26PM  
01:53PM  
01:02PM  
Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sneed Michael EEVP, Global Corp Aff & COODec 09Option Exercise62.2054,6623,399,976110,741Dec 10 06:19 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Sale152.9354,6628,359,46056,079Dec 10 06:19 PM
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Option Exercise63.7516,1151,027,32374,535Sep 04 02:58 PM
Wengel Kathryn EEVP, Chief GSC OfficerSep 02Sale153.5216,1152,473,93858,420Sep 04 02:58 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesJul 28Sale147.4729,0004,276,63021,682Jul 28 06:43 PM
JOHNSON & JOHNSON10% OwnerJun 30Buy17.00725,00012,325,0003,670,516Jul 02 04:58 PM
PEREZ WILLIAM DDirectorMar 13Buy127.6950063,84316,030Mar 17 04:24 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 21Option Exercise90.4419,2241,738,61975,039Feb 25 04:23 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 21Sale147.9639,2245,803,58335,815Feb 25 04:23 PM
Ullmann Michael HExec VP, General CounselFeb 13Option Exercise0.0020,3260152,697Feb 18 05:03 PM
Wolk Joseph JExec VP, CFOFeb 13Option Exercise0.007,080021,387Feb 18 05:03 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 13Option Exercise0.0015,809065,532Feb 18 05:03 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 13Option Exercise0.0022,2310110,559Feb 18 05:03 PM
Decker Robert JController, CAOFeb 13Option Exercise0.001,499013,946Feb 18 05:03 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 13Option Exercise0.00105,6680220,373Feb 18 05:03 PM
Gorsky AlexChairman, CEOFeb 13Option Exercise0.00107,0160496,472Feb 18 05:03 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 13Option Exercise0.0013,747056,496Feb 18 05:03 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 13Option Exercise0.003,692057,259Feb 18 05:03 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 13Option Exercise0.0011,836061,219Feb 18 05:03 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 13Option Exercise0.0039,3810270,900Feb 18 05:03 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 13Option Exercise0.0016,0840115,813Feb 18 05:03 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 03Option Exercise0.0048,3120123,450Feb 04 07:31 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 03Option Exercise0.0038,650058,154Feb 04 07:31 PM
Sneed Michael EEVP, Global Corp Aff & COOJan 30Option Exercise62.6258,1283,639,975107,511Feb 03 06:28 PM
Sneed Michael EEVP, Global Corp Aff & COOJan 30Sale149.3958,1288,683,56849,383Feb 03 06:28 PM